Jeffrey Trigilio, Chief Financial Officer at Cullinan Oncology, Inc. (CGEM), sold 30,000 shares at $28.85 ($854K) on 2021-09-08, disclosed to the SEC on 2021-09-09.
Open-market sale of $854k CGEM by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $27.83 | 5,487 | $153K | 17.9% |
| 2 | $27.83 | 5,487 | $153K | 17.9% |
| 3 | $28.85 | 9,513 | $274K | 32.1% |
| 4 | $28.85 | 9,513 | $274K | 32.1% |
| Total | $28.48 avg | 30,000 | $854K | 100% |
| Filing → |
| CGEM | SELL | 2023-12-13 | $15K | — | Filing → |
| CGEM | SELL | 2023-06-21 | $5K | — | Filing → |
| CGEM | SELL | 2023-06-14 | $4K | — | Filing → |